FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to pharmaceutics and concerns an injectable dosage form of oligopeptides for treating multiple sclerosis. The injectable dosage form contains oligopeptides GGDRGAPKRGSGKDSHH; GFGYGGRASDYKSAHK; QGTLSKIFKLGGRDSRSGSPMARR, enclosed into liposomes, consisting of mixed mannosyalised dipalmitoyl phosphatidyl ethanolamine, 2,3-dipalmitoyl-sn-glycero-1-phosphatidylcholine, as well as lactose as a cryoprotector and alpha tocopherol as an antioxidant, as well as a method for preparing it.
EFFECT: group of invention provides enhancing the therapeutic effect.
2 cl, 2 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| LIPOSOMES CONTAINING OLIGOPEPTIDES - FRAGMENTS OF MYELIN BASIC PROTEIN, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATING MULTIPLE SCLEROSIS | 2009 |
|
RU2448685C2 |
| DOSAGE FORM OF SPECIFIC IMMUNOBIOLOGICAL MEDICINE FOR TREATING AND PREVENTING HIV INFECTION AND PREPARATION METHOD THEREOF | 2014 |
|
RU2600031C2 |
| PEPTIDE FROM THE COMPOSITION OF THE IMMUNOGLOBULIN HUMAN HEAVY CHAIN, SUITABLE FOR TREATMENT OF MULTIPLE SCLEROSIS | 2016 |
|
RU2646817C1 |
| LIPOSOMES CONTAINING OLIGOPEPTIDE FRAGMENTS OF MYELIN BASIC PROTEIN, PHARMACEUTICAL COMPOSITION AND METHOD FOR MULTIPLE SCLEROSIS TREATMENT | 2013 |
|
RU2639497C2 |
| ACTH-LIKE PEPTIDE WITH IMMUNOSUPRESSOR FUNCTION | 2017 |
|
RU2681317C1 |
| LIPOSOMAL AGENT BASED ON UBIQUINOL AND PREPARATION METHOD THEREOF | 2015 |
|
RU2605616C1 |
| METHOD OF LYOPHILIZED LIPOSOME PREPARING | 1997 |
|
RU2144352C1 |
| LIPOSOMAL DRUG FOR USE IN THE TREATMENT OF MALIGNANT NEOPLASM | 2017 |
|
RU2756755C2 |
| METHOD FOR PRODUCING LIPID MIXTURE AND LIPOSOMAL ORAL ANTIVIRAL THERAPEUTIC AND PROPHYLACTIC AGENT USING SAID LIPID MIXTURE | 2020 |
|
RU2746320C1 |
| LIPOSOMAL PERORAL ANTIVIRAL TREATMENT-AND-PROPHYLACTIC AGENT ON BASIS OF HUMAN INTERFERON ALPHA | 2008 |
|
RU2361572C1 |
